• Refine Query
  • Source
  • Publication year
  • to
  • Language
  • 2
  • 1
  • 1
  • Tagged with
  • 5
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • About
  • The Global ETD Search service is a free service for researchers to find electronic theses and dissertations. This service is provided by the Networked Digital Library of Theses and Dissertations.
    Our metadata is collected from universities around the world. If you manage a university/consortium/country archive and want to be added, details can be found on the NDLTD website.
1

A comparative study on the toxicity of ibogaine and serotonin

Dhahir, Hashim Ismail January 1971 (has links)
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
2

A Reexamination of US Heroin Policy

Fogel, Daniel 01 January 2011 (has links)
Misguided drug policy in the United States has led to many severe social and economic problems that have burgeoned over the past century. I analyzed heroin policy specifically, investigating new treatment methods and alternative decriminalization policies that would ameliorate some of these problems.
3

En kvalitativ studie om behandling av missbruk med naturläkemedlet Ibogain / A qualitative study about treatment of substance abuse with the natural remedy Ibogaine

Andersson, Sofie, Angefred, Kristina January 2010 (has links)
<p>Studiens syfte var att undersöka om naturläkemedlet Ibogain kunde vara en bra behandling för missbruk. För att kunna besvara detta har kvalitativa intervjuer genomförts med fyra personer som genomgått Ibogain-behandling och en psykolog/psykoterapeut på en beroendeklink, Lars Lundell. Utöver dessa intervjuer har en klinik i London besökts som utför Ibogain-behandling. På kliniken gjordes en observationsstudie av behandlingen, samt intervjuer med klinikchefen Dr Brackenridge och en av hans patienter, i uppsatsen kallad Will. Studiens perspektiv utgår från informanterna och våra egna observationer om Ibogain-behandling. Intervjufrågorna har bildats utifrån dessa 3 frågeställningar:</p><p>1. Hur går en behandling tillväga rent praktiskt?</p><p>2. Hur har livet påverkats av Ibogain-behandling?</p><p>3. Vilken syn har informanterna på Ibogain-behandling?</p><p>I analysen söktes gemensamma nämnare och skillnader i informanternas svar, uppdelat i de tidigare nämnda frågeställningarna. Sedan tolkades denna information med hjälp av litteratur, observationer och egna tankar.</p><p>I studien ges en mycket samstämmig syn på att utan Ibogain-behandling hade troligtvis inte informanterna varit i livet idag.</p><p>Resultatet visar tydligt på att informanterna upplever att de fått en mycket bättre livskvalité efter behandlingen.</p><p>Av de uppgifter som framkommit i studien anser vi att Ibogain är att rekommendera.</p> / <p>The purpose of this study was to investigate if the naturally occurring substance Ibogaine could be a good treatment for substance abuse. In order to answer this question, qualitative interviews have been performed with five persons who have been subject to Ibogain treatment and one psychologist/psychotherapist at an addiction treatment clinic, Lars Lundell.</p><p>In addition to these interviews an Ibogaine treatment clinic located in London has been visited. At the clinic an observational study of the treatment was carried out as well as interviews with the responsible physician Dr Brackenridge one of his patients, named Will in this paper. The perspective of this study is substance abuse treatment with Ibogaine based on the informants experiences and our own observations.</p><p>The interviews have been formed based on the following three questions:</p><p>1. How is a treatment carried out?</p><p>2. How have their lives been affected by the Ibogain treatment?</p><p>3. What are the informant’s views on Ibogain treatment?</p><p>The analysis was made looking for similarities and dissimilarities in the informants answers, divided into the three previously described questions. This information was subsequently interpreted using literature, observations and our own thoughts.</p><p>The study shows that among the informants there is an almost unanimous opinion that without the Ibogaine treatment they would not be alive today.</p><p>The study clearly shows that the informants feel that they have a much better quality of life after the treatment. The conclusion of this study is that Ibogaine can be a successful treatment for substance abuse.</p>
4

En kvalitativ studie om behandling av missbruk med naturläkemedlet Ibogain / A qualitative study about treatment of substance abuse with the natural remedy Ibogaine

Andersson, Sofie, Angefred, Kristina January 2010 (has links)
Studiens syfte var att undersöka om naturläkemedlet Ibogain kunde vara en bra behandling för missbruk. För att kunna besvara detta har kvalitativa intervjuer genomförts med fyra personer som genomgått Ibogain-behandling och en psykolog/psykoterapeut på en beroendeklink, Lars Lundell. Utöver dessa intervjuer har en klinik i London besökts som utför Ibogain-behandling. På kliniken gjordes en observationsstudie av behandlingen, samt intervjuer med klinikchefen Dr Brackenridge och en av hans patienter, i uppsatsen kallad Will. Studiens perspektiv utgår från informanterna och våra egna observationer om Ibogain-behandling. Intervjufrågorna har bildats utifrån dessa 3 frågeställningar: 1. Hur går en behandling tillväga rent praktiskt? 2. Hur har livet påverkats av Ibogain-behandling? 3. Vilken syn har informanterna på Ibogain-behandling? I analysen söktes gemensamma nämnare och skillnader i informanternas svar, uppdelat i de tidigare nämnda frågeställningarna. Sedan tolkades denna information med hjälp av litteratur, observationer och egna tankar. I studien ges en mycket samstämmig syn på att utan Ibogain-behandling hade troligtvis inte informanterna varit i livet idag. Resultatet visar tydligt på att informanterna upplever att de fått en mycket bättre livskvalité efter behandlingen. Av de uppgifter som framkommit i studien anser vi att Ibogain är att rekommendera. / The purpose of this study was to investigate if the naturally occurring substance Ibogaine could be a good treatment for substance abuse. In order to answer this question, qualitative interviews have been performed with five persons who have been subject to Ibogain treatment and one psychologist/psychotherapist at an addiction treatment clinic, Lars Lundell. In addition to these interviews an Ibogaine treatment clinic located in London has been visited. At the clinic an observational study of the treatment was carried out as well as interviews with the responsible physician Dr Brackenridge one of his patients, named Will in this paper. The perspective of this study is substance abuse treatment with Ibogaine based on the informants experiences and our own observations. The interviews have been formed based on the following three questions: 1. How is a treatment carried out? 2. How have their lives been affected by the Ibogain treatment? 3. What are the informant’s views on Ibogain treatment? The analysis was made looking for similarities and dissimilarities in the informants answers, divided into the three previously described questions. This information was subsequently interpreted using literature, observations and our own thoughts. The study shows that among the informants there is an almost unanimous opinion that without the Ibogaine treatment they would not be alive today. The study clearly shows that the informants feel that they have a much better quality of life after the treatment. The conclusion of this study is that Ibogaine can be a successful treatment for substance abuse.
5

Ibogaino ir noribogaino toksiškumo ir farmakokinetinių savybių tyrimas / Research of toxicity and pharmacokinetic properties of ibogaine and noribogaine

Kubilienė, Asta 06 January 2014 (has links)
Ibogainas yra indolo grupės alkaloidas, išskiriamas iš augalo Tabernanthe iboga Baill. (Apocynaceae). Šis alkaloidas mažina priklausomybę nuo opiatų bei lengvina abstinencijos požymius. Noribogainas – ibogaino aktyvusis metabolitas, sukeliantis mažiau nepageidaujamų reiškinių. Darbo tikslas: ištirti ibogaino ir noribogaino toksiškumą ir farmakokinetines savybes taikant eksperimentinį laboratorinių pelių modelį. Uždaviniai: Nustatyti ibogaino ir noribogaino toksiškumą, apskaičiuojant šių medžiagų vidutinę mirtinąją dozę (LD50) laboratorinėms pelėms. Pritaikyti ir validuoti efektyviosios skysčių chromatografijos (ESC) metodiką ibogaino ir noribogaino analizei laboratorinių pelių kraujo plazmoje ir vidaus organuose. Išskirti ibogainą ir noribogainą iš laboratorinių pelių kraujo plazmos ir vidaus organų mėginių ir atlikti kiekybinį įvertinimą. Nustatyti ibogaino ir noribogaino farmakokinetinius parametrus pelių kraujo plazmoje ir organuose. Ištirti vienkartinės ir kartotinių ibogaino ir noribogaino dozių įtaką šių medžiagų kaupimuisi pelių organuose. Nustatyti farmakokinetiniai parametrai atskleidžia kiekybinius ibogaino ir noribogaino kitimus organizme, įtakojančius biologiškai aktyvios medžiagos veiksmingumą, o medžiagų kaupimasis pelių organuose padeda įvertinti toksinio poveikio riziką. Gauti tyrimų rezultatai naudingi ir informatyvūs siekiant toliau atlikti klinikinius tyrimus su žmonėmis. / Ibogaine is a psychoactive alkaloid extracted from the Tabernanthe Iboga Baill. (Apocynaceae). This alkaloid reduces dependence on opiates and attenuates withdrawal symptoms. Ibogaine is metabolized to metabolite – noribogaine. Noribogaine appears less likely to produce the adverse effects associated with ibogaine. The aim of work is to test the toxicity and pharmacokinetic properties of ibogaine and noribogaine by conducting tests with white laboratory mice. The objectives of the research work are as follows: To determine the toxicity of ibogaine and noribogaine by calculating the median lethal dose (LD50) in laboratory mice. To adapt and validate the methodology of high-performance liquid chromatography (HPLC) for the analysis of ibogaine and noribogaine in the blood plasma and internal organs of laboratory mice. To determine ibogaine and noribogaine in plasma and organs of mice. To determine pharmacokinetic parameters of ibogaine and noribogaine in mice blood plasma and organs. To test the influence of repeated doses of ibogaine and noribogaine on the accumulation of these substances in organs of mice. Pharmacokinetic properties reveal quantitative variation of ibogaine and noribogaine in the body, influencing the effectiveness of biologically active substances. Accumulation test of these substances helps to assess the risk of toxicity. The obtained results are useful and informative in order to continue to carry out clinical trials with humans.

Page generated in 0.0364 seconds